Qualitek Labs guides for 35-40% revenue growth in FY27

Qualitek Labs has done something many nano-caps avoid: it gave explicit FY27 guidance. Revenue growth of 35-40%, EBITDA margins of 25-27%, and PAT margins of 15-17% are now on the table. The numbers supplement the already-disclosed FY26 results, which were known from prior filings, but the forward-looking targets are new. For a company with a market cap of ₹434 crore, this level of disclosure shifts the narrative from rearview reporting to forward accountability. The guidance suggests management expects the acquisition momentum and operational discipline to continue. The test will be whether quarterly results deliver against these targets. If they do, Qualitek could re-rate; if not, the stock may lose credibility. For now, the direction is clear.